Proof of concept: manufacturers' risk factors of false positives/negatives are associated with strength of concordance between FibroTest (FT) and liver stiffness measurements (LSM).
收藏NIAID Data Ecosystem2026-03-06 收录
数据链接：
官方服务：
资源简介：
*FT as enpoint for LSM AUROCs, LSM as endpoint for FT AUROCs. **If LSM was taken as endpoint same results were observed: AUROC of patients with manufacturer risk factors (n = 666) was 0.71 (0.67–0.75) vs 0.81 (0.78–0.84) in patients without risk factors (n = 1338; P = 0.0001).
创建时间：
2008-12-04
